T1	Participants 49 79	persistent atrial fibrillation
T2	Participants 270 278	patients
T3	Participants 351 464	51 patients who experienced the first episode of persistent AF receiving amiodarone (600 mg) daily for 4-6 weeks.
T4	Participants 692 705	control group
T5	Participants 728 736	patients
